Key Takeaway: Bangladeshi families facing a cancer diagnosis increasingly travel to India for care that isn’t yet widely available at home — proton therapy, CAR-T cell therapy, robotic surgery, and bone marrow transplant, delivered by named specialists such as Dr. Ashok Vaid (Medanta), Dr. Suresh Advani (Jaslok Hospital, Padma Bhushan awardee), and Dr. Prasad at the Apollo Proton Cancer Centre. This guide consolidates treatment options, procedure-specific outcome data, leading oncologists and hospitals, costs in BDT, and the medical visa process into one reference.
Table of Contents
1. Why Bangladeshi Cancer Patients Choose India
Bangladesh has only one JCI-accredited hospital, and access to advanced radiation technology (IMRT, IGRT, proton therapy), specialised surgical oncologists, and bone marrow transplant facilities remains limited. According to the World Health Organisation, cancer is a leading cause of death worldwide, and access to timely, specialised care is one of the strongest predictors of outcome.
India offers over 60 JCI-accredited hospitals with comprehensive oncology departments, multidisciplinary tumour boards, and technology including proton therapy and CAR-T cell therapy. Treatment is also considerably less expensive than in Singapore, the Gulf, or the West — a full course of cancer treatment in India typically costs $3,000–$12,000, compared with $15,000–$35,000 in Singapore and $50,000–$150,000+ in the United States.
2. How to Choose the Right Oncologist
Not every oncologist is the right fit for every cancer. Consider:
- Specialisation and subspecialisation — a breast cancer specialist is not necessarily the right choice for a lung or blood cancer. Look for oncologists who focus on your specific cancer type.
- Volume and experience — high-volume oncologists see more variation and complications, and the National Comprehensive Cancer Network notes that high-volume centres tend to achieve better outcomes.
- Hospital affiliation — JCI or NABH accreditation, in-house pathology and imaging, and clinical trial access all matter.
- International patient experience — a track record with Bangladeshi patients specifically, including language and documentation support.
- Communication style — a pre-travel video consultation is the best way to judge whether a specialist explains things clearly and compassionately.
3. Leading Oncologists Treating Bangladeshi Patients
Rather than a generic cost claim, here is who is actually treating international patients, and what they are known for. MedicHorizon can coordinate a pre-travel video consultation with any of these specialists.
Dr. Ashok Vaid — Medical Oncologist, Medanta – The Medicity, Gurugram
One of India’s most senior medical oncologists, with a career spanning haematological malignancies and solid tumours. Former head of medical oncology at AIIMS, with extensive experience treating international patients.
Dr. Vinod Raina — Medical Oncologist, Fortis Memorial Research Institute, Gurugram
A pioneer of medical oncology in India who helped develop the country’s earliest bone marrow transplant programmes. Specialises in lung cancer, GI cancers, and lymphoma.
Dr. Suresh Advani — Medical Oncologist, Jaslok Hospital, Mumbai
Among the earliest medical oncologists to practise in India, and a Padma Bhushan awardee (2012), India’s third-highest civilian honour. His decades of clinical work span leukaemia, lymphoma, breast cancer, and paediatric cancers, using immunotherapy, targeted therapy, and precision oncology protocols.
Dr. Rakesh Chopra — Medical Oncologist, Artemis Hospital, Gurugram
Specialises in haematological malignancies and stem cell transplantation, with active involvement in precision-medicine research and extensive experience with international patients.
Dr. Subhash Gupta — Surgical Oncologist, Indraprastha Apollo Hospital, New Delhi
A high-volume surgeon specialising in GI cancers, hepatobiliary surgery, and liver tumours, with a focus on complex resections and minimally invasive technique.
Dr. Prasad — Radiation Oncologist, Apollo Proton Cancer Centre, Chennai
Practises at South Asia’s first proton therapy centre, with a focus on paediatric cancers, brain tumours, and head-and-neck cancers where sparing healthy tissue is critical.
Dr. Rajesh Mistry — Thoracic Oncologist, Kokilaben Dhirubhai Ambani Hospital, Mumbai
Specialises in lung cancer, mediastinal tumours, and thoracic malignancies, with expertise in minimally invasive thoracic surgery and active involvement in lung cancer screening programmes.
4. Types of Cancer Treatment Available in India
- Surgery: Minimally invasive and robotic tumour removal with preservation of healthy tissue.
- Chemotherapy: Systemic drug therapy administered in cycles, following National Cancer Institute protocols.
- Radiation therapy: IMRT, IGRT, and brachytherapy, delivered to ASTRO standards.
- Targeted therapy: For HER2-positive breast cancer, EGFR-mutated lung cancer, and other molecularly defined cancers.
- Immunotherapy: Checkpoint inhibitors and CAR-T cell therapy for melanoma, lung cancer, and triple-negative breast cancer.
- Proton therapy: Precision radiation that spares surrounding tissue — particularly relevant for paediatric, brain, and recurrent cancers.
- Bone marrow transplant: For leukaemia, lymphoma, multiple myeloma, and non-cancerous blood disorders like thalassaemia.
- HIPEC (Heated Intraperitoneal Chemotherapy): For advanced abdominal cancers, delivered directly to the abdominal cavity during surgery.
5. Treatment and Outcomes by Cancer Type
Breast Cancer
Breast cancer is one of the most common cancers among Bangladeshi women. Treatment includes breast-conserving surgery, mastectomy, radiation, chemotherapy, hormone therapy, and targeted therapy, with oncoplastic reconstruction available at leading centres. A 2025 study published in Frontiers in Public Health reported a 10-year overall survival of 79.0% and a 10-year disease-free survival of 76.2% for early-stage breast cancer patients treated in India.
Lung Cancer
Treatment depends on stage and molecular profile, with EGFR and ALK mutation testing guiding targeted therapy decisions. A 2024 study from an Indian state cancer centre reported a 2-year overall survival of 74.3% and 3-year overall survival of 70.6% for non-small cell lung cancer patients undergoing curative-intent surgery. Video-assisted thoracoscopic surgery (VATS) and stereotactic body radiation therapy (SBRT) are available for patients who cannot undergo open surgery.
Liver Cancer
Liver cancer is relatively common in Bangladesh due to hepatitis B and C rates. Options include surgery, living-donor liver transplant, TACE, targeted therapy, and immunotherapy. India’s living-donor liver transplant programmes report one-year survival exceeding 90% at leading centres. A 2026 South Indian cohort study on first-line lenvatinib for advanced hepatocellular carcinoma reported a median overall survival of 13.3 months.
Prostate Cancer
Robotic-assisted radical prostatectomy (Da Vinci system), HIFU, and brachytherapy are available, offering nerve-sparing precision and faster recovery than open surgery.
Blood Cancers and Bone Marrow Transplant
A 2025 study of an Indian BMT unit found that an interdisciplinary, team-based approach reduced day-100 mortality and hospital-acquired infection rates by roughly 70% after implementing a structured care programme, while raising genomics-based testing to 95% of patients.
Immunotherapy
A 2024 study in JCO Global Oncology examined immune checkpoint inhibitor use across 100 Indian patients and found that per-body-weight, lower-dose regimens produced acceptable outcomes while improving access in lower-resource settings. A 2026 phase III trial (DELII) found that ultra-low-dose nivolumab improved overall survival versus chemotherapy in pretreated solid tumours, with fewer severe side effects.
Proton Therapy
A 2025 Indian study on proton therapy for breast cancer reported meaningfully reduced cardiac radiation exposure — notable given that Indians have a higher rate of cardiovascular disease at younger ages than some other populations. Early experience with image-guided proton therapy for craniopharyngioma in India was described as well tolerated, with limited toxicity.
6. Top Cancer Hospitals in India for Bangladeshi Patients
Delhi NCR
- Indraprastha Apollo Hospital, New Delhi — comprehensive oncology, 2,500+ robotic procedures, JCI accredited
- BLK-Max Super Speciality Hospital, New Delhi — leading BMT and haematology unit, NABH accredited
- Medanta – The Medicity, Gurugram — comprehensive tumour board approach, advanced robotic surgery
- Fortis Memorial Research Institute, Gurugram — JCI/NABH accredited, CyberKnife radiation
Chennai
- Apollo Proton Cancer Centre — South Asia’s first proton therapy centre, JCI accredited
- Gleneagles Global Health City, Chennai — multi-organ transplant, comprehensive oncology
- Sri Ramachandra Medical Centre, Chennai — university-led research hospital, NABH accredited
Mumbai
- Kokilaben Dhirubhai Ambani Hospital, Mumbai — advanced radiation and surgical oncology, JCI accredited
- Tata Memorial Hospital, Mumbai — India’s premier government cancer centre, highest treatment volume, extensive clinical trial access
Bangalore
- Fortis Hospital, Bangalore — comprehensive cancer care, NABH accredited
- Manipal Hospitals, Bangalore — advanced radiation therapy and molecular diagnostics, JCI accredited
All institutions in the MedicHorizon network hold NABH or JCI accreditation.
7. Cancer Treatment Costs in Bangladeshi Taka (BDT)
Exchange rate used: 1 USD ≈ 120 BDT (approximate). Costs vary by cancer type, stage, hospital tier, and treatment protocol — the figures below are indicative, and MedicHorizon provides a personalised estimate after reviewing your case.
| Treatment | India (USD) | Approximate BDT |
|---|---|---|
| Cancer Surgery | $3,000 – $8,000 | ৳3,60,000 – ৳9,60,000 |
| Chemotherapy (per cycle) | $500 – $2,000 | ৳60,000 – ৳2,40,000 |
| Radiation Therapy (full course) | $2,500 – $6,000 | ৳3,00,000 – ৳7,20,000 |
| Immunotherapy (per cycle) | $1,500 – $3,000 | ৳1,80,000 – ৳3,60,000 |
| Proton Therapy (full course) | $15,000 – $30,000 | ৳18,00,000 – ৳36,00,000 |
| Bone Marrow Transplant | $15,000 – $35,000 | ৳18,00,000 – ৳42,00,000 |
| Full Treatment Course (surgery + chemo + radiation) | $8,000 – $25,000 | ৳9,60,000 – ৳30,00,000 |
For context, private cancer treatment in Bangladesh can cost ৳15,00,000 – ৳40,00,000 or more, and a comparable full course in Singapore runs $15,000–$35,000, versus $50,000–$150,000+ in the United States.
8. The Treatment Process, Step by Step
- Initial consultation and staging — medical records and imaging are reviewed; additional PET-CT, MRI, biopsy review, or molecular testing may be recommended.
- Tumour board review — medical, surgical, and radiation oncologists, plus pathologists, review the case together.
- Treatment planning — your oncologist explains the recommended plan, expected outcomes, and side effects.
- Treatment — surgery, chemotherapy cycles, or 4–6 weeks of daily radiation, depending on protocol.
- Response assessment — imaging and blood tests determine whether the plan needs adjustment.
- Follow-up and survivorship — coordinated monitoring between your Indian oncologist and your doctor in Bangladesh.
9. Medical Visa Process
Bangladeshi patients require a Medical Visa (MED) for cancer treatment in India. You will generally need:
- Passport valid for at least 6 months, with 2 blank pages
- Medical reports confirming diagnosis (biopsy, imaging)
- Referral letter from a registered doctor in Bangladesh
- Hospital appointment/invitation letter from the treating Indian hospital (MedicHorizon coordinates this)
- Proof of financial means (typically USD 150+ per applicant)
- Recent passport-sized photographs, and National ID or birth certificate copy
Processing typically takes 5–10 working days. Bangladeshi patients may travel with up to two medical attendants under the standard visa allowance; some hospitals can support additional attendant applications on request. Always confirm current requirements with IVAC Bangladesh and the official Indian Visa Online portal before applying.
10. Frequently Asked Questions
How long does cancer treatment take in India?
It varies by cancer type and stage. Surgery alone may need 1–2 weeks in India. Chemotherapy involves multiple cycles over 3–6 months, often with travel back and forth. Radiation typically requires 4–7 weeks of daily sessions. Your oncologist will set a personalised timeline.
What is the actual survival/success rate for my type of cancer?
This depends entirely on cancer type, stage, and individual factors — there’s no single “success rate” that applies across all cancers. As a reference point, published Indian outcome data includes 10-year overall survival of 79.0% for early-stage breast cancer, and 2-year overall survival of 74.3% for surgically treated non-small cell lung cancer. Ask your oncologist for outcome data specific to your diagnosis and stage.
Is proton therapy available for Bangladeshi patients?
Yes, at the Apollo Proton Cancer Centre in Chennai, South Asia’s first proton therapy facility. It is particularly relevant for paediatric cancers, brain and spinal tumours, and cases requiring re-irradiation.
Can I get a second opinion before starting treatment?
Yes. MedicHorizon coordinates video consultations and tumour board reviews with Indian oncologists before you travel, so you can confirm a diagnosis or treatment plan without committing to a trip first.
Can family members accompany the patient?
Yes. Medical visas typically allow one attendant per patient, with additional family members able to apply for tourist visas. MedicHorizon can help arrange accommodation for accompanying family.
Will language be a barrier?
Most oncologists at major Indian hospitals are fluent in English, and MedicHorizon provides Bengali-speaking coordinators throughout the journey.
11. How MedicHorizon Assists Bangladeshi Patients
MedicHorizon is a health hospitality consultancy — not a hospital or medical provider. We do not diagnose, treat, prescribe, or offer medical opinions; all medical decisions remain between you and your licensed physicians. What we coordinate:
- Oncologist matching based on your diagnosis, stage, and cancer type
- Tumour board coordination for multidisciplinary case review before you travel
- Pre-arrival video consultations with your chosen oncologist
- Medical visa assistance, including the hospital invitation letter
- Travel and accommodation, including airport transfers
- Bengali-speaking coordination throughout your journey
- Transparent, all-inclusive cost estimates in Bangladeshi Taka
- Post-treatment follow-up, with teleconsultations at 3, 6, and 12 months
📞 Contact us today for a free consultation and personalised cost estimate
📧 Email: contactmedichorizon@gmail.com
🌐 MedicHorizon Hospital Directory
This article is for general informational and educational purposes only. MedicHorizon is a health hospitality consultancy, not a medical provider, hospital, or licensed medical practitioner. We do not diagnose, treat, prescribe, or offer medical opinions. Information on oncologists, hospitals, and outcomes is drawn from publicly available sources and does not constitute medical advice or a guarantee of outcome. Verify current details independently and consult a qualified oncologist before making treatment decisions.